Insights from 2023 ASH Annual Meeting
L

ASH 2023 Insights: "A Novel Beta Globin Frameshift Mutation Causing Autosomal Dominant Beta Thalassemia"

By Insights from 2023 ASH Annual Meeting FEATURING Lisa Bilston
By Insights from 2023 ASH Annual Meeting FEATURING Lisa Bilston
100 views
December 15, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

14:10
Hematology Content

An ITP Case Study in a Patient Who Is Non-responsive to Multiple Cou…

Feat. T. Gernsheimer

Featured Video

04:26
Pharmacosmos Hematology

An Introduction to an IV iron replacement therapy

Feat. H. Bahrain

Related Content

AUTOPLAY
15:39

Thalassemias: Overview of Pathophysiology and Treatment

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

K. Fertrin

1.0K views
17:38

Impact and Risks of Chronic Anemia in Thalassemia Patients

Farrukh Shah

606 views
16:09

Case-Based Discussion: Managing Non-Transfusion-Dependent Thalassemia

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Taher

1.5K views
33:17

Managing Benign Hematology Disorders

Indy Hematology Review

C. Kessler

602 views
04:54

New

Thalassemia: Overview of Pathophysiology and Risk for Malignancies

Ali Taher

192 views
05:59

Mitapivat for Thalassemia: Results From the Ph3 ENERGIZE-T Study

Stefan Eber

154 views
42:10

Highlights in Red Cell and Platelet Disorders From ASH 2023

Insights from 2023 ASH Annual Meeting

M. Blinder

298 views
33:48

Beyond Transfusion: Current Treatment Options for Managing Thalassem…

Abdulrahman Nasiri

89 views
18:15

Updates in Cellular Therapy for Sickle Cell Disease and Beta-Thalass…

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

S. Peslak

108 views
13:57

ASH 2023 Insights: "Pyruvate Kinase Activators - Targeting Red Cell …

Insights from 2023 ASH Annual Meeting

K. Kuo

130 views
10:22

State-of-the-Art in Managing Thalassemias

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

M. Cappellini

96 views
08:05

Mitapivat in Adults With Alpha- or Beta-Non-Transfusion-Dependent Th…

Ali Taher

36 views
12:24

The Role of Luspatercept in Transfusion-Dependent Patients With Beta…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Tombak

45 views
15:43

New

Importance of PK Activation in Thalassemias

Ilham Youssry

14 views
22:07

Thalassemia Intermedia: Cases and Discussion

XV Eurasian Hematology-Oncology Congress - EHOC 2024

J. Abiyounis

18 views
19:58

Luspatercept and Blood Transfusion Management in Beta Thalassemia an…

XV Eurasian Hematology-Oncology Congress - EHOC 2024

A. Tombak

19 views
08:41

ASH 2022 Long-Term Outcomes of Patients With TDT Followed Up to 8 Ye…

ASH 2022 Conference Coverage

M. Walters

98 views
09:49

Bu-Cy or Treosulfan-Flu-Thiotepa-Based Myeloablative Conditioning fo…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

N. Bayram

13 views
16:30

New

Supportive Management of Thalassemia With Complications: A Case Pres…

XV Eurasian Hematology-Oncology Congress - EHOC 2024

N. Karadaş

7 views
03:11

A Case of Thalassemia Minor Coexisting with Chronic Myeloproliferati…

XV Eurasian Hematology-Oncology Congress - EHOC 2024

E. Buyukasik

8 views